Alterations in Erythrocyte Defonmability and Functions in End-Stage Renal Disease

被引:0
|
作者
Sudnitsyna, J. S. [1 ,2 ]
Skverchinskaya, E. A. [2 ]
Zubina, I. M. [3 ]
Suglobova, E. D. [3 ]
Vlasov, T. D. [3 ]
Smirnov, A., V [3 ]
Vasiliev, A. V. [3 ]
Ruzhnikova, T. O. [2 ]
Kaljuzhnyi, B. A. [2 ]
Mindukshev, I., V [2 ]
Borisov, Yu A. [3 ]
机构
[1] Russian Acad Sci, Ctr Theoret Problems Physicochem Pharmacol, Moscow 119991, Russia
[2] Russian Acad Sci, Sechenov Inst Evolutionary Physiol & Biochem, St Petersburg 194223, Russia
[3] Pavlov First St Petersburg State Med Univ, St Petersburg 197022, Russia
来源
BIOLOGICHESKIE MEMBRANY | 2021年 / 38卷 / 06期
关键词
erythrocytes; end-stage renal disease (ESRD); oxidative stress; ammonium stress; osmotic fragility test; RED-BLOOD-CELLS; CHRONIC KIDNEY-DISEASE; OXIDATIVE STRESS; UREMIC TOXINS; ANEMIA; MECHANISM; TRANSPORT; AMMONIUM; SURVIVAL; SURFACE;
D O I
10.31857/S0233475521060116
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
End-stage renal disease (ESRD) is associated with a range of erythrone alterations, such as structural and functional changes of circulating erythrocytes, which are the potential risk factors to cause erythrocyte malfunctions and corresponding anemia of different severity; however, the mechanisms of such changes in erythrocytes remain understudied. Here we used flow cytometry for estimation of the changes in intracellular esterase activity, phosphatidylserine externalization, and reticulocyte count and state; laser diffraction for osmotic and ammonium stress tests, and spectrophotometry for oxidized hemoglobin evaluation in erythrocytes of patients with ESRD before and after the hemodialysis (HD) session. Erythrocytes of ESRD patients were more osmotically fragile and had increased swelling rate in ammonium stress test. HD did not affect erythrocyte deformability but lead to hemoglobin oxidation to ferryl forms and triggered apoptosis-like events, such as a decrease in the intracellular esterase activity and increase in the number of annexin-positive cells. Our data indicate that uremic syndrome, combined with the mechanical effects of the HD system, challenges the erythron of HD patients and contributes to a multifactorial decrease in erythrocyte function and aggravation of renal anemia.
引用
收藏
页码:450 / 463
页数:14
相关论文
共 50 条
  • [21] Hypertension in end-stage renal disease
    Martínez-Maldonado, M
    KIDNEY INTERNATIONAL, 1998, 54 : S67 - S72
  • [22] End-Stage Renal Disease and Pregnancy
    Nadeau-Fredette, Annie-Claire
    Hladunewich, Michelle
    Hui, Dini
    Keunen, Johannes
    Chan, Christopher T.
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2013, 20 (03) : 246 - 252
  • [23] Pregnancy and End-Stage Renal Disease
    Tangren, Jessica
    Nadel, Molly
    Hladunewich, Michelle A.
    BLOOD PURIFICATION, 2018, 45 (1-3) : 194 - 200
  • [24] Adiponectin and end-stage renal disease
    Markaki A.
    Psylinakis E.
    Spyridaki A.
    Hormones, 2016, 15 (3) : 345 - 354
  • [25] Pharmacotherapy of end-stage renal disease
    Schmid, Holger
    Schiffl, Helmut
    Lederer, Stephan R.
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (04) : 597 - 613
  • [26] Silicosis and end-stage renal disease
    Steenland, K
    Rosenman, K
    Socie, E
    Valiante, D
    SCANDINAVIAN JOURNAL OF WORK ENVIRONMENT & HEALTH, 2002, 28 (06) : 439 - 442
  • [27] HYPERTENSION IN END-STAGE RENAL DISEASE
    PAGE, LB
    NEW ENGLAND JOURNAL OF MEDICINE, 1969, 280 (18): : 1018 - &
  • [28] Epidemiology of end-stage renal disease
    Roderick, P
    CLINICAL MEDICINE, 2002, 2 (03) : 200 - 204
  • [29] End-stage renal disease in leprosy
    Lomonte, C
    Chiarulli, G
    Cazzato, F
    Giammaria, B
    Marchio, G
    Losurdo, N
    Antonelli, M
    Casucci, F
    Basile, C
    JOURNAL OF NEPHROLOGY, 2004, 17 (02) : 302 - 305
  • [30] Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease
    Blacher, J
    Demuth, K
    Guerin, AP
    Safar, ME
    Moatti, N
    London, GM
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (04) : 535 - 541